Cargando…

The economic pressures for biosimilar drug use in cancer medicine

The main rationale for using biosimilar drugs is for cost saving. The market development for biosimilar drugs will therefore depend on the degree to which cost saving measures are required by nations, medical insurers and individuals and the absolute savings that could be gained by switching from or...

Descripción completa

Detalles Bibliográficos
Autor principal: Cornes, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291824/
https://www.ncbi.nlm.nih.gov/pubmed/22249658
http://dx.doi.org/10.1007/s11523-011-0196-3